Home Featured

Featured

Random

MEC Announces Submission of Listing Statement to the CSE in Coordination with Albert Labs RTO

Psychedelic Research Bulletin: May 2023

PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study

Mydecine’s Chief Medical Officer, Dr. Rakesh Jetly, to Participate at Horizons’ Veterans & Families Forum on November 10, 2021

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

Pα+ Psychedelic Bulletin #198: New Data Offers Look at Spravato’s Long-Term...

Whole-Body Effects of Psychedelics Part 2 – Blood and Immune System

Numinus to Participate in a Water Tower Research Fireside Chat on...

Psychedelic Bulletin: California Decrim. Bill Put on Pause; MindMed Inks Real-World...

Horizons ETFs Completes Rebalance of World’s First Psychedelics ETF

MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder...

PT227- Dr. Anne Wagner – Couples Therapy, MDMA, and MAPS

Activated: A reMind Afterparty

Psychedelic Health – Vital report explores employment in the psychedelics industry

12 3...309 Page 1 of 309

EDITOR PICKS

Pα+ February 2026 Psychedelic Bill Roundup

Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines

The State of the Psychedelic Industry & Open Questions (Video)

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.